[go: up one dir, main page]

DE60118798D1 - Fragmente der intron a von citomegalovirus - Google Patents

Fragmente der intron a von citomegalovirus

Info

Publication number
DE60118798D1
DE60118798D1 DE60118798T DE60118798T DE60118798D1 DE 60118798 D1 DE60118798 D1 DE 60118798D1 DE 60118798 T DE60118798 T DE 60118798T DE 60118798 T DE60118798 T DE 60118798T DE 60118798 D1 DE60118798 D1 DE 60118798D1
Authority
DE
Germany
Prior art keywords
fragments
intron
citomegalovirus
cytomegalovirus
cmv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60118798T
Other languages
English (en)
Other versions
DE60118798T2 (de
Inventor
Kent Thudium
Mark Selby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of DE60118798D1 publication Critical patent/DE60118798D1/de
Application granted granted Critical
Publication of DE60118798T2 publication Critical patent/DE60118798T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
    • C12N2840/445—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor for trans-splicing, e.g. polypyrimidine tract, branch point splicing

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Separation, Recovery Or Treatment Of Waste Materials Containing Plastics (AREA)
  • Perforating, Stamping-Out Or Severing By Means Other Than Cutting (AREA)
  • Package Closures (AREA)
DE60118798T 2000-10-13 2001-10-12 Fragmente des introns a des cytomegalovirus Expired - Lifetime DE60118798T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24050200P 2000-10-13 2000-10-13
US240502P 2000-10-13
PCT/US2001/032050 WO2002031137A2 (en) 2000-10-13 2001-10-12 Cytomegalovirus intron a fragments

Publications (2)

Publication Number Publication Date
DE60118798D1 true DE60118798D1 (de) 2006-05-24
DE60118798T2 DE60118798T2 (de) 2007-04-12

Family

ID=22906778

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60118798T Expired - Lifetime DE60118798T2 (de) 2000-10-13 2001-10-12 Fragmente des introns a des cytomegalovirus

Country Status (11)

Country Link
US (2) US6893840B2 (de)
EP (1) EP1373524B1 (de)
JP (1) JP4445703B2 (de)
CN (1) CN1247785C (de)
AT (1) ATE323166T1 (de)
AU (1) AU2002211710A1 (de)
CA (1) CA2425852C (de)
DE (1) DE60118798T2 (de)
ES (1) ES2261489T3 (de)
WO (1) WO2002031137A2 (de)
ZA (1) ZA200302667B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0027088D0 (en) * 2000-11-06 2000-12-20 Glaxo Group Ltd DNA expression vectors
JP3630414B2 (ja) * 2002-05-21 2005-03-16 インターナショナル・ビジネス・マシーンズ・コーポレーション 塩基配列のクラスタ生成システム、塩基配列のクラスタ生成方法、該クラスタ生成方法を実行するためのプログラム、および該プログラムを記憶したコンピュータ可読な記録媒体、および塩基配列情報提供システム
ES2363972T3 (es) * 2003-06-09 2011-08-22 Corixa Corporation Vectores de adn.
EA010056B1 (ru) * 2003-10-10 2008-06-30 Паудерджект Вэксинс, Инк. Конструкции нуклеиновых кислот
JP2007508037A (ja) * 2003-10-14 2007-04-05 バイオジェン・アイデック・エムエイ・インコーポレイテッド Ｆｌｐ媒介性の組換え
GB0507997D0 (en) * 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
CA2600986A1 (en) * 2005-04-22 2006-10-26 Lonza Biologics Plc. Mammalian expression vector comprising the mcmv promoter and first intron of hcmv major immediate early gene
US20120129770A1 (en) * 2009-06-22 2012-05-24 Rajyashri Karur Ramakrishna Novel polynucleotide molecules for enhanced gene expression
EP2474611A4 (de) * 2009-09-04 2013-06-12 Nat Inst Biomedical Innovation Verstärker für einen promoter und verwendung davon
US20120100573A1 (en) * 2010-10-21 2012-04-26 Thudium Kent B Cytomegalovirus intron a fragments
US11060083B2 (en) 2013-07-19 2021-07-13 Larix Bioscience Llc Methods and compositions for producing double allele knock outs
US9663782B2 (en) 2013-07-19 2017-05-30 Larix Bioscience Llc Methods and compositions for producing double allele knock outs
EP3851537B1 (de) * 2014-04-25 2023-12-27 Genethon Behandlung von hyperbilirubinämie
US11617788B2 (en) 2018-07-09 2023-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Viral promoters and compositions and methods of use thereof
KR102798616B1 (ko) * 2019-12-20 2025-04-22 (주)셀트리온 목적 단백질의 고발현을 위한 인트론을 포함하는 발현 카세트 및 이의 이용
WO2021130503A1 (en) 2019-12-24 2021-07-01 Synpromics Limited Regulatory nucleic acid sequences
GB202005732D0 (en) 2020-04-20 2020-06-03 Synpromics Ltd Regulatory nucleic acid sequences
WO2022008510A2 (en) 2020-07-06 2022-01-13 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Intron-encoded extranuclear transcripts for protein translation, rna encoding, and multi-timepoint interrogation of non-coding or protein-coding rna regulation
CN114958914B (zh) * 2022-06-06 2023-09-26 新乡医学院 一种人类及哺乳动物细胞附着体表达载体、构建方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939018A (en) * 1984-10-10 1999-08-17 Kawasaki Steel Corporation Martensitic stainless steels for seamless steel pipe
CA1341482C (en) 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
US5620896A (en) * 1992-03-23 1997-04-15 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
US5739018A (en) 1996-08-07 1998-04-14 The Regents Of The University Of California Packaging cell lines for pseudotyped retroviral vectors
US6025338A (en) 1996-10-17 2000-02-15 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
ATE241965T1 (de) * 1999-01-13 2003-06-15 Univ Johns Hopkins Med Genetische immunisierung mit gleichzeitiger verabreichung von nukleinsäuren und zytokinen
CA2378539A1 (en) 1999-07-06 2001-01-11 Merck & Co., Inc. Adenovirus carrying gag gene hiv vaccine

Also Published As

Publication number Publication date
JP4445703B2 (ja) 2010-04-07
US20050191727A1 (en) 2005-09-01
ES2261489T3 (es) 2006-11-16
AU2002211710A1 (en) 2002-04-22
EP1373524A2 (de) 2004-01-02
CA2425852C (en) 2009-09-29
US20050079488A1 (en) 2005-04-14
ZA200302667B (en) 2004-07-05
CA2425852A1 (en) 2002-04-18
JP2004511229A (ja) 2004-04-15
ATE323166T1 (de) 2006-04-15
CN1247785C (zh) 2006-03-29
US7846687B2 (en) 2010-12-07
WO2002031137A2 (en) 2002-04-18
WO2002031137A3 (en) 2002-10-31
CN1469930A (zh) 2004-01-21
US6893840B2 (en) 2005-05-17
DE60118798T2 (de) 2007-04-12
EP1373524B1 (de) 2006-04-12

Similar Documents

Publication Publication Date Title
DE60118798D1 (de) Fragmente der intron a von citomegalovirus
DE69637816D1 (de) Der expression von genen, welche spezifisch sind für die stärkebiosynthese
DK1196637T3 (da) Peptidacceptor-ligeringsmetoder
WO2003005999A8 (en) Methods of treating cytokine mediated diseases
MXPA02004666A (es) Gelatinas recombinantes.
WO2003011115A3 (en) Peptide-based multimeric targeted contrast agents
PL344475A1 (en) Bridged indenopyrrolocarbazoles
AU7381098A (en) Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
DE60128149D1 (en) Putrescin-n-methyltransferasepromotor
AU6114700A (en) Novel system for the sequential, directional cloning of multiple dna sequences
AU8738401A (en) Novel kallikrein gene
FI961666A7 (fi) Restenosiksen geeniterapia, jossa käytetään adenovirusvektoria
DK0981525T3 (da) (2-(2-Thienyl)-ethylamino)-(2-halophenyl)-acetonitriler som mellemprodukter og fremgangsmåde til deres fremstilling
DK0817851T3 (da) DNA, der koder for humant papillomvirus type 18
AU2002212505A1 (en) Dna expression vectors
AU2003234198A1 (en) Novel genes, compositions, and methods for modulating the unfolded protein response
WO2004099388A3 (en) Cbl-b polypeptides, complexes and related methods
SG169325A1 (en) Promoters for expression in modified vaccinia virus ankara
MXPA02006167A (es) Promocion de la angiogenesis con survivina.
AU7216498A (en) Inhibitors of the urokinase receptor
GB9919409D0 (en) Baculovirus expression system
NO20015330D0 (no) Ny promoter for genekspresjon
AU2001252591A1 (en) Novel promoters and gene expression method by using the promoters
DE69733948D1 (de) In vivo herstellung von replicativen molekülen
NO20020064D0 (no) Chlamysin B antibakterielt protein, gen som koder for dette samt et ekspresjonssystem for dette

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS,INC.(N.D.GES, US